We are pleased to announce an upcoming presentation at the Cambridge Biomedical Campus featuring the launch of the new Olink Target Neurodegeneration Panel in the T48 format, offering absolute quantification. Dr Heleen Kool, Business Development Manager for Olink’s Target Portfolio, will introduce the panel and discuss its relevance and applications in neurodegenerative research.
Date: Friday, 7 November
Time: 2:00–4:00 PM
Cambridge Biomedical Campus: Main Seminar Room, CIMR, The Keith Peters Building, Hills Road, Cambridge, CB2 0XY
There will be opportunities for 1-to-1 conversations with Dr Kool before and after the presentation.
All are welcome to attend, with particular interest for research groups working in the field.
Refreshments.